AbbVie (ABBV)
$173.15
0.46 (0.26%)
ABBV Stock Quote Delayed 30 Minutes
5 Top Stock Trades for Monday
Biogen soared 20% and gave a big lift to biotech stocks. IQiyi is finally coming back down to reasonable levels. Here are our top five stock trades for Monday.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 ā FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report ā FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out ā FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why ā FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.93M
Day's Range
$172.77 - $174.59
52-Week Range
$135.85 - $182.89
Dividend & Yield
$5.92 (3.42%)
ABBV Stock Predictions, Articles, and AbbVie News
9 Highest-Yielding Dividend Aristocrats to Buy Today
These dividend aristocrats to buy today have a cult-like following among income investors, and for good reason. To be a dividend aristocrat, a company must be a member of the S&P 500 Index and have paid higher dividends for 25 consecutive years.
AbbVie Inc Stock Up on Strong Earnings, Guidance Update
AbbVie (ABBV) stock was up on Thursday following the release of a positive earnings report for the first quarter of the year.
AbbVie Inc. Is a Clear Value Play in Biotech Stocks
AbbVie stock is not bouncing back after investors bailed on it following potentially negative clinical results. For value investors, ABBV trades at a discount to its peers but investors seem skittish of biotech's risks. When that changes, ABBV stock will be one of the first to recover.
Tread Very Carefully When Investing in AnaptysBio Inc
ANAB is up on positive clinical studies posted in the last few months. But the small sample size and risks ahead could hurt the stock in the near term.
AbbVie Inc Stock Dives on Lung Cancer Drug Results
AbbVie (ABBV) stock was falling hard today following results from a Phase 2 study of lung cancer drugĀ Rovalpituzumab Tesirine.
Strong Buy for AbbVie (ABBV) This Week
At $114.93, AbbVie (ABBV) a Strong Buy based on the most recent SEC filings, and comparative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
At $118.94, AbbVie (ABBV) a Strong Buy based on the most recent SEC filings, and comparative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
The Strong Buy for AbbVie (ABBV) this week is based on the latest stock market rankings, and relative pricing of its shares.
AbbVie (ABBV) a Strong Buy at $114.56
AbbVie (ABBV) a Strong Buy at $114.56 based on the most current analysis, and comparative pricing of its shares.
AbbVie (ABBV) a Strong Buy at $114.56
AbbVie (ABBV) a Strong Buy at $114.56 based on the most current analysis, and comparative pricing of its shares.
Strong Buy for AbbVie (ABBV) This Week
AbbVie (ABBV) remains a Strong Buy this week based on the most current relative pricing of its shares and analysis.
AbbVie (ABBV) a Strong Buy at $117.98
At $117.98, AbbVie (ABBV) a Strong Buy based on the latest SEC filings, and comparative pricing of its shares.
6 Notable Dividend Stocks Boost Payouts, Including Coca-Cola (KO)
Six notable dividend stocks recently raised their payouts, including Coca-Cola (KO). Here's what you need to know about each.
5 Solid Dividend Growth Stocks Amid Rising Rates
Dividend growth stocks pose strong fundamentals and are lucrative, especially given the new tax legislation in the United States, rising yields and heightened v...
